Background/Aim: Every day, a substantial proportion of the general population experiences the distressing and frightening signs of an upcoming psychiatric illness. The consequences can be enormous because severe psychiatric disorders typically cause the loss of the ability to work and often mean a long-term burden for both the patients and their families. Even though most developed countries have an exceptionally high density of general practitioners and psychiatrists in private practice, getting a mental health appointment and seeing a doctor is often very difficult for patients with acute psychiatric symptoms. This study aimed at quantifying the time delay involved in seeking medical attendance when psychiatric disorders begin to develop. Methods: Two female actors with well-proven experiences of realistically simulating the clinical presentation of depression and psychotic disorders made systematic phone calls to 106 psychiatrists in private practice and 106 general practitioners (GPs) of the Zurich City area. The actors asked for an appointment at the doctor's earliest convenience due to acute psychiatric symptoms. We assessed (1) the number of phone calls it took to reach each doctor; (2) the time it took to book an appointment; (3) the time span between the first phone call and the earliest available appointment, and (4) the possibility of personal contact with a doctor prior to booking the appointment. Results: A total of 383 phone calls were made by the two actors (227 to psychiatrists and 156 to GPs) which resulted in analyzable data from 102 psychiatrist and 106 GP practices. Two thirds (68%) of the phone calls to the psychiatrists in private practice were answered by voice mail, compared to 21% among the GPs. A personal contact was established with 56% of the psychiatrists and 95% of the GPs. On average, 7.3 phone calls were necessary to successfully book an appointment with a psychiatrist. Almost half of the psychiatrists (45.6%) were not accepting new patients so appointments were able to be booked in less than one third of cases (30.4%). The situation was significantly better with GPs (p < 0.002) but depended on clinical diagnosis (p < 0.01). The waiting time to seeing a psychiatrist often far exceeded 7 days. Conclusions: A high density of psychiatrists in private practice does not necessarily improve the long and troublesome circumstances of obtaining a mental health appointment in acute psychiatric situations. Under these circumstances, a considerable proportion of patients might give up prior to seeing a doctor. This has important implications - many patients could miss the potential benefits from timely therapeutic interventions which can significantly modify both the acute and long-term course of the illness. The situation might be improved if psychiatrists and GPs joined forces in the form of group practices or networks as this would readily ensure (1) a rapid mental health triage by assessing and categorizing the urgency of mental health-related problems, and (2) timely therapeutic interventions whenever indicated.

1.
WHO Resource Book on Mental Health, Human Rights and Legislation. WHO, 2005.
2.
Stassen HH, Angst J, Hell D, Scharfetter C, Szegedi A: Is there a common resilience mechanism underlying antidepressant drug response? Evidence from 2,848 patients. J Clin Psychiatry 2007;68:1195-1205.
3.
Szegedi A, Jansen WT, Van Willigenburg AP, Van der Meulen E, Stassen HH, Thase ME: Early improvement as a predictor of treatment outcome in patients with major depressive disorder: why the first 2 weeks really matter - evidence from 6,562 patients. J Clin Psychiatry 2009;70:344-353.
4.
Stassen HH, Anghelescu IG, Angst J, Böker H, Lötscher K, Rujescu D, Szegedi A, Scharfetter C: Predicting response to psychopharmacological treatment. survey of recent results. Pharmacopsychiatry 2011;44:263-272.
5.
Christodoulou GN, Christodoulou NG: Early intervention in psychiatry. Early Interv Psychiatry 2007;1:7-8.
6.
Brenner R, Madhusoodanan S, Puttichanda S, Chandra P: Primary prevention in psychiatry - adult populations. Ann Clin Psychiatry 2010;22:239-248.
7.
Pedrelli P, Farabaugh AH, Zisook S, Tucker D, Rooney K, Katz J, Clain AJ, Petersen TJ, Fava M: Gender, depressive symptoms and patterns of alcohol use among college students. Psychopathology 2011;44:27-33.
8.
Rhodes KV, Vieth TL, Kushner H, Levy H, Asplin BR: Referral without access: for psychiatric services, wait for the beep. Ann Emerg Med 2009;54:272-278.
9.
Goldner EM, Jones W, Lan Fang M: Access to and waiting time for psychiatrist services in a Canadian urban area: a study in real time. Can J Psychiatry 2011;56:474-480.
10.
Boyd JW: The crisis in mental health care: a preliminary study of access to psychiatric care in Boston. Ann Emerg Med 2011;58:218-219.
11.
Williams ME, Latta J, Conversano P: Eliminating the wait for mental health services. J Behav Health Serv Res 2008;35:107-114.
12.
Collins KA, Wolfe VV, Fisman S, DePace J, Steele M: Managing depression in primary care: community survey. Can Fam Physician 2006;52:878-879.
13.
Fleury MJ, Bamvita JM, Aubé D, Tremblay J: Clinical practice settings associated with GPs who take on patients with mental disorders. Healthc Policy 2010;5:90-104.
14.
Kates N, McPherson-Doe C, George L: Integrating mental health services within primary care settings: the Hamilton Family Health Team. J Ambul Care Manage 2011;34:174-182.
15.
Regestein QR: Psychiatrists' views of managed care and the future of psychiatry. Gen Hosp Psychiatry 2000;2:97-106.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.